Responses
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – other biologic treatment
THU0111 Secukinumab treatment improves ACR50, HAQ-DI and eular remission rates in patients with rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.